'No discussions' over AstraZeneca-Bristol Myers deal, senior source says - Reuters
'No discussions' over AstraZeneca-Bristol Myers deal, senior source says Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxOMFpOMDBiVmpKVlBJazhKdEJ2RWhjLUlpNUl4Nm04OVF4TnUtSzhETjhYS0NJN2NtWDRDMFlBMHlRWm9OOVduTFBqWmZJbzFxbVRSajM2NFhmYkxaSE1xOVZQN004Wi1QRDMwNzhsMVdNbHZ3Qk42Vm50andHUWdVY0hITGFKQ2xMTTBqT3RYM2VQMGhTWTJfczdHeE5PY0djdFVpMGtnRlNoQUtXN2RvUg?oc=5" target="_blank">'No discussions' over AstraZeneca-Bristol Myers deal, senior source says</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up - Reuters
AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up Reuters
September 28, 2026 at 10:15 PMAstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination - Reuters
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination Reuters
October 2, 2026 at 06:58 AMBioNTech to shutter three sites in Germany as no buyers emerge - Reuters
BioNTech to shutter three sites in Germany as no buyers emerge Reuters
September 28, 2026 at 08:00 PMMerck licenses SciBrunch cancer drug in deal worth up to $2.13 billion - Reuters
Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion Reuters
September 28, 2026 at 04:14 PMNovartis strikes up to $7.8 billion mRNA deal with China's Abogen - Reuters
Novartis strikes up to $7.8 billion mRNA deal with China's Abogen Reuters
October 2, 2026 at 10:57 AMBayer to invest $2.2 billion in new US pharma site - Reuters
Bayer to invest $2.2 billion in new US pharma site Reuters
October 2, 2026 at 07:19 PM